Competitor Landscape: Sjogrens Syndrome: Leading Pharma Entities Collaborate to Develop New Drugs
Characterized by excessive dryness of the mouth and eyes sjogren's syndrome is widely prevalent auto-immune disorder. With no apparent cure for sjogren's syndrome, pharmaceutical organizations are aimed at offering apt therapeutic solutions that arrest frequency of symptoms and reciprocal disease prognosis.
View full press release